NAPNAP Daily News

The NAPNAP Daily news is available for Members Only. You will need to login as a Member to to view all of the news.

Asfotase Alfa Appears To Be Safe, Effective For Treating Long-Term Hypophosphatasia In Children, Researchers Say.
Endocrine Today (12/21, Schaffer) reported, “Infants and young children with perinatal or infantile hypophosphatasia treated with asfotase alfa before age three years experienced ‘substantial early improvements’ in skeletal mineralization and respiratory...